Molecular Imaging Current Events | Page 2

Molecular Imaging Current Events, Molecular Imaging News Articles.
Sort By: Most Viewed | Most Recent
Page 2 of 25 | 1000 Results
SNMMI publishes appropriate use criteria for bone scintigraphy in prostate and breast cancer
The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify bone metastases) in patients with prostate or breast cancer. This is the first in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging. (2017-04-06)

Radioactive optical imaging and 'quantum dot' nano-imaging at the forefront of molecular medicine
During SNM's 57th Annual Meeting, investigators presented the results of a multidisciplinary study involving the capture of radiation luminescence and radioactive-excited nanoparticles to help detect subtle signs of disease. (2010-06-07)

Influence of the Journal of Nuclear Medicine jumps 25%
The Journal of Nuclear Medicine again ranks among the top 5 medical imaging journals in the world. JNM continues to lead among nuclear medicine journals, with the highest impact factor (7.354), the highest immediacy index, the highest number of citations, the highest 5-year impact factor, the highest number of citable articles, and the highest influence score. (2019-06-27)

SNM warns patients about imaging test delays due to worldwide Mo-99 shortage
Molybdenum-99, or Mo-99, is a radioactive substance produced in only five nuclear reactors in the world -- two of which are out of service due to extended repairs. From March 21 until April 11, the medical community will experience one of the most significant disruptions ever in the supply of Mo-99. (2010-03-18)

'Scout scans' map the way in non-Hodgkin's lymphoma treatment
According to a study presented at SNM's 57th Annual Meeting, molecular imaging can evaluate and optimize non-Hodgkin's lymphoma therapy with Zevalin, a front-line radioimmunotherapy drug that uses a dose of radioactive material and mimics the body's own immune response to target and kill cancer cells while sparing nearby healthy tissues. (2010-06-07)

UQ opens new era in cancer research and drug development
New cancer-fighting drugs could emerge from The University of Queensland in coming years, thanks to a state-of-the-art imaging facility opened today. (2017-03-28)

Peter S. Conti, M.D., Ph.D., receives SNMMI 2016 Paul C. Aebersold Award
Peter S. Conti, M.D., Ph.D., FACNP, FACR, professor of radiology, pharmaceutical sciences and biomedical engineering, and director of the Molecular Imaging Center, Keck School of Medicine, University of Southern California, Los Angeles, has been named the 2016 recipient of the prestigious Paul C. Aebersold Award. Conti was presented the award by the Society of Nuclear Medicine and Molecular Imaging during its annual meeting, held June 11-15 in San Diego, Calif. (2016-06-12)

Opti-SPECT/PET/CT: 5 different imaging systems now combined
their pick, biomedical researchers can now conduct five different imaging studies in one scan with a state-of-the-art preclinical molecular imaging system that scientists unveiled during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. (2014-06-09)

Eli Lilly and Co. joins SNM's Clinical Trials Network
Eli Lilly and Co., has joined SNM's Clinical Trials Network -- making it the third major company to formally support this initiative to facilitate the development of promising therapeutic medicines. (2010-03-25)

2014 SNMMI Annual Meeting highlights research and looks to future
Top research from around the world and the latest advances in technology were brought together for the 2014 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in St. Louis, Mo. June 7-11. (2014-06-30)

SNM molecular imaging summit introduces clinical trials network
More than 150 physicians, imagers and pharmaceutical developers convened in Clearwater, Fla., Feb. 8, for an intensive workshop examining the need for streamlined drug discovery through the integration of imaging biomarkers into multi-center clinical trials. (2009-02-17)

Annual SNM MI summit introduces the clinical trials network
SNM will devote its annual Molecular Imaging Summit to introducing the new SNM Clinical Trials Network, Feb. 8-9, 2009, at the Hilton Clearwater Hotel, Clearwater, Fla. In part, the program will explain requirements of participation in the Clinical Trials Network, which was designed to facilitate cost-effective drug development through the integration of imaging biomarkers into Phase 1, 2, 3 and 4 therapeutics clinical trials. In addition, the workshop will explore key issues involved with imaging participation in multi-center trials. (2009-01-13)

Hybrid scanner brings molecular functioning to the forefront
A major barrier to developing a hybrid positron emission tomography/magnetic resonance imaging system could be removed by using a novel approach for reconstructing data, according to researchers at SNM's 56th Annual Meeting in Toronto. (2009-06-15)

New molecular imaging technologies for detecting cellular processes
A group of researchers at Universidad Carlos III de Madrid have designed and developed a biomedical scanner that detects cellular processes at the molecular level and indicates malfunctioning of an organ before said malfunction can produce an anatomical change. (2011-01-11)

Molecular imaging agent coupled with 'motion frozen' processing improves heart imaging
Molecular imaging of the heart just got better, according to a study revealed at SNM's 57th Annual Meeting. Combining a potential new imaging agent with a molecular imaging technique that reduces blur caused by the motion of the heart and lungs could lead to unprecedented image quality when conducting myocardial perfusion imaging, a procedure used to evaluate blood flow to the heart. (2010-06-07)

MRI scans could be 'acceptable alternative' to x-rays
Magnetic resonance imaging (MRI) could be set to replace the traditional x-ray and autopsy, according to an editorial in this week's BMJ. (2004-06-10)

Combined imaging agents advance PET imaging of cancer
Research presented at SNM's 58th Annual Meeting is taking targeted molecular imaging to a new level by combining two commonly used imaging agents into one molecular imaging procedure. (2011-06-06)

Envisioning the future of neuroscience
Today, SNM's Molecular Imaging Center of Excellence kicked off a two-day symposium bringing together individuals from multiple scientific disciplines -- including chemistry, engineering, physics, molecular biology, neurosciences and imaging sciences -- to promote the emerging field of molecular neuroimaging. (2010-05-06)

Molecular MRI aims at component of multiple cancers
A relatively new biomarker called prostate-specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). (2015-06-08)

SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers
SNM's Clinical Trials Network today announced that several leading commercial providers of PET radiopharmaceuticals in Europe have registered their manufacturing sites with the network. SNM's Clinical Trials Network is an initiative designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multicenter clinical trials. (2009-07-23)

Blood-sugar lowering medications may increase risk for false positive results in cancer screenings
A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F-FDG), which mimics sugar inside the body. (2010-06-07)

SNM's 2010 Annual Meeting reveals latest developments in molecular imaging and nuclear medicine
More than 5,100 physicians, technologists and members of the molecular imaging and nuclear medicine communities gathered in Salt Lake City for SNM's 57th Annual Meeting, held June 5-9. The meeting featured more than 1,400 scientific papers that represented groundbreaking research and development worldwide in molecular imaging and nuclear medicine. (2010-06-16)

Molecular breast imaging protocol unmasks more cancer
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging technique that scouts new cancer as it begins to metastasize. Best results also indicate that imaging could be improved by injecting the agent the day prior to surgical resection, according to research unveiled at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. (2014-06-09)

SNMMI publishes appropriate use criteria for V/Q imaging in pulmonary embolism
The Society of Nuclear Medicine and Molecular Imaging has published appropriate use criteria for ventilation/perfusion (V/Q) imaging in pulmonary embolism. This is the second in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging. (2017-05-01)

SNM applauds temporary freeze on Medicare cuts
On April 16, the president signed a bill granting temporary relief from looming cuts to Medicare reimbursement rates. Although a positive step, the medical community -- along with millions of patients -- continues to face significant threats to medical coverage for critical diagnostic imaging tests and therapeutics. (2010-04-16)

National Comprehensive Cancer Network and SNM join to advance oncology imaging research
The National Comprehensive Cancer Network and the Society of Nuclear Medicine are pleased to announce a collaboration to advance research for cancer imaging and therapies. Specifically, NCCN will work with SNM to qualify imaging sites for upcoming research projects utilizing molecular imaging in clinical trials. (2011-03-08)

Transplanted cardiac cells can be monitored with microPET imaging
Results of a study using microPET imaging technology to monitor the survival of transplanted rat cardiac cells within the myocardium - the middle layer of the wall of the heart composed of cardiac muscle fibers that allow the heart to contract - of living rats showed that microPET indicated the presence and location of viable transplanted cells. (2003-06-23)

SNMMI image of the year -- theranostic drug unites imaging and therapy for prostate cancer
A novel molecular imaging technology not only detects prostate cancer that has spread throughout the body, but also provides a potent and minimally invasive method of radiotherapy, reveal researchers at the 2015 Society of Nuclear Medicine and Molecular Imaging annual meeting. (2015-06-08)

Molecular imaging may be best for capturing renal transplant complications
A recent study presented at SNM's 57th Annual Meeting suggests that the use of both physiological and structural images acquired from single photon emission computed tomography and X-ray computed tomography hybrid imaging can help clinicians to better diagnose and treat patients suffering from a number of renal-transplant associated complications. (2010-06-07)

Molecular imaging prototype looks deep into soft tissues of the brain and other organs
Research unveiled at SNM's 57th Annual Meeting points to the possibility of a new hybrid molecular imaging system that uses single photon emission tomography and magnetic resonance technology. The new technology could provide a greater depth of information about an array of biological processes and anatomical information including soft-tissue contrast, which is important for many diagnoses. (2010-06-07)

Prototype breast cancer imaging system may improve patient care
A prototype breast imaging system combining positron emission tomography and magnetic resonance imaging technologies could greatly improve breast cancer imaging capabilities, according to researchers at SNM's 56th Annual Meeting. (2009-06-15)

PET/CT imaging of prostate cancer proves accurate biopsy guide
Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy and pre-operative planning to root out the full extent of disease, researchers revealed at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. (2016-06-15)

Medical imaging benefits far outweigh radiation risks
In response to a recent report by the National Council on Radiation Protection and Measurement stating that the US population is exposed to seven times more radiation from medical imaging exams than in 1980, SNM urges Americans to consider the proven benefits of such imaging. (2009-03-05)

Enzyme-inhibition could revolutionize molecular imaging
The prominent role a single enzyme plays in cancer imaging has eluded researchers for years, but not anymore. This discovery could pave new avenues in nuclear medicine. The enzyme, called neutral endopeptidase, has a way of breaking down most radiopeptide imaging agents in the body. Researchers have developed an elegant new concept that improves molecular imaging, according to study results presented during the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. (2014-06-09)

SNM/Nihon Medi-Physics sponsor new fellowship program for Japanese physicians
SNM, the world's largest molecular imaging and nuclear medicine society, recently announced a new, two-year $24,000 fellowship program in the US for Japanese physicians in the early stages of their career. (2007-11-07)

New 'microbead' radiotherapy more effective with molecular imaging
Research unveiled at SNM's 57th Annual Meeting may change the way that a novel form of radiotherapy is set up and tested prior to treatment. This technique, known as radiomicrosphere therapy, involves the injection of tiny highly radioactive beads that (2010-06-07)

When eyes aren't enough: Computer analysis can help doctors diagnose severe heart disease
A study revealed at SNM's 57th Annual Meeting urges physicians using molecular imaging for the diagnosis of heart disease to use computer data analysis rather than visual interpretation alone. The study shows that when combined, these techniques can improve early detection and diagnosis, especially in conditions that can be more difficult to catch early on, such as diseased arteries. (2010-06-07)

Molecular imaging gets to the root of rheumatoid arthritis
Study uses SPECT, PET systems and respective imaging agents to detect the inflammation involved in the ongoing pathology of osteoarthritis. (2014-06-09)

PET imaging could lead to better care for neuroendocrine cancer
A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. (2012-06-11)

SNMMI 2015-2017 Wagner-Torizuka Fellowship recipients announced
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce the recipients of the 2015-2017 SNMMI Wagner-Torizuka Fellowship. This two-year fellowship, founded in 2008 by the late Henry N. Wagner, Jr., M.D., and the late Kanji Torizuka, M.D., Ph.D., is designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers. (2015-09-01)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.